A Prospective Study of a Mosaic Embryo Transfer
Part of paid clinical trials in Lone Tree, Colorado.
- Sponsor
- Colorado Center for Reproductive Medicine
- Study ID
- NCT04472156
- Status
- Recruiting
Conditions
- Infertility
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 45 Years
- Healthy Volunteers
- Accepted
Interventions
- Transfer of mosaic embryo — PROCEDURESubjects will transfer a mosaic embryo transferred to their uterus
Study Details
This research is a prospective study in which the purpose is to investigate the clinical outcomes following the transfer of a mosaic embryo (presence of both chromosomally normal and abnormal cells) that has been screened for preimplantation genetic testing (PGT).
Key Dates
- Start date
- Oct 15, 2020
- Status verified
- Feb 2024
- Primary completion
- Jun 15, 2026
- Completion
- Dec 15, 2026
Study Design
- Enrollment
- 250 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Transfer of mosaic embryoWomen will have a mosaic embryo transferred to their uterus after in vitro fertilization (IVF) with pre implantation genetic testing completed at Colorado Center for Reproductive Medicine.
Primary Outcome Measure
Evaluation of Implantation rate [ Time Frame: 3-4 weeks after embryo transfer ]
Central Contacts
- Rachel Makloski, RN303-788-8300
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Colorado Center for Reproductive Medicine | Lone Tree | Colorado | 80124 | Rachel Makloski, RN |
Find similar trials in Lone Tree, CO
By research site
Related Studies
- DNA Analysis of Discarded Media Drops From the Clinical IVF CyclesRecruiting · Colorado Center for Reproductive Medicine · Lone Tree, Colorado
- Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic SyndromePHASE1 · Recruiting · University of Colorado, Denver · Aurora, Colorado
- In Vitro Maturation of Human EggsRecruiting · Colorado Center for Reproductive Medicine · Lone Tree, Colorado
- Study to Create Potential Cell-Based Therapies to Treat Human Disease and DisabilityEnrolling By Invitation · Stanford University · Stanford, California